Display options
Cite
Volinia S, Bertagnolo V, Grassilli S, et al. Levels of miR-126 and miR-218 are elevated in ductal carcinoma . Oncotarget. 2018;9(34):23543-23553doi: 10.18632/oncotarget.25261.
Volinia, S., Bertagnolo, V., Grassilli, S., Brugnoli, F., Manfrini, M., Galasso, M., Scatena, C., Mazzanti, C. M., Lessi, F., Naccarato, G., Caligo, A., Bianchini, E., Piubello, Q., Orvieto, E., Rugge, M., Natali, C., Reale, D., Vecchione, A., Warner, S., Croce, C. M., & Capitani, S. (2018). Levels of miR-126 and miR-218 are elevated in ductal carcinoma . Oncotarget, 9(34), 23543-23553. https://doi.org/10.18632/oncotarget.25261
Volinia, Stefano, et al. "Levels of miR-126 and miR-218 are elevated in ductal carcinoma ." Oncotarget vol. 9,34 (2018): 23543-23553. doi: https://doi.org/10.18632/oncotarget.25261
Volinia S, Bertagnolo V, Grassilli S, Brugnoli F, Manfrini M, Galasso M, Scatena C, Mazzanti CM, Lessi F, Naccarato G, Caligo A, Bianchini E, Piubello Q, Orvieto E, Rugge M, Natali C, Reale D, Vecchione A, Warner S, Croce CM, Capitani S. Levels of miR-126 and miR-218 are elevated in ductal carcinoma . Oncotarget. 2018 May 04;9(34):23543-23553. doi: 10.18632/oncotarget.25261. eCollection 2018 May 04. PMID: 29805754; PMCID: PMC5955110.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2018 May 04;9(34):23543-23553. doi: 10.18632/oncotarget.25261. eCollection 2018 May 04.

Levels of miR-126 and miR-218 are elevated in ductal carcinoma .

Oncotarget

Stefano Volinia, Valeria Bertagnolo, Silvia Grassilli, Federica Brugnoli, Marco Manfrini, Marco Galasso, Cristian Scatena, Chiara Maria Mazzanti, Francesca Lessi, Giuseppe Naccarato, Adelaide Caligo, Enzo Bianchini, Quirino Piubello, Enrico Orvieto, Massimo Rugge, Cristina Natali, Domenico Reale, Andrea Vecchione, Sarah Warner, Carlo Maria Croce, Silvano Capitani

Affiliations

  1. Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara 44121, Italy.
  2. LTTA Centre, University of Ferrara, Ferrara 44121, Italy.
  3. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy.
  4. Pisa Science Foundation, Pisa 56121, Italy.
  5. Pathology Division, S. Anna University Hospital, Ferrara 44124, Italy.
  6. Department of Diagnostic and Pathology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona 37126, Italy.
  7. Department of Medicine DIMED, University of Padova, Padova 35121, Italy.
  8. Pathology Division, Santa Maria della Misericordia Hospital, Rovigo 45100, Italy.
  9. Department of Pathology, St. Andrea University Hospital, University of Rome, La Sapienza, Rome 00185, Italy.
  10. Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.

PMID: 29805754 PMCID: PMC5955110 DOI: 10.18632/oncotarget.25261

Abstract

A substantial number of ductal carcinoma

Keywords: DCIS; EMT; breast cancer; breast tumor progression; over-diagnosis

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no conflicts of interest.

References

  1. JAMA Oncol. 2015 Oct;1(7):888-96 - PubMed
  2. Cancer Res. 2011 Sep 1;71(17):5635-45 - PubMed
  3. Mol Oncol. 2013 Oct;7(5):859-69 - PubMed
  4. Lancet. 2012 Nov 17;380(9855):1778-86 - PubMed
  5. Breast Cancer Res Treat. 2015 Jul;152(1):183-191 - PubMed
  6. J Clin Invest. 2009 Jun;119(6):1420-8 - PubMed
  7. PLoS Genet. 2010 Mar 12;6(3):e1000879 - PubMed
  8. J Pathol. 2012 May;227(1):42-52 - PubMed
  9. J Clin Oncol. 2015 Mar 1;33(7):709-15 - PubMed
  10. PLoS One. 2009 Jul 03;4(7):e6146 - PubMed
  11. Cell Rep. 2016 Jul 26;16(4):1166-1179 - PubMed
  12. Nat Cell Biol. 2013 Mar;15(3):284-94 - PubMed
  13. Annu Rev Pathol. 2014;9:287-314 - PubMed
  14. J Natl Cancer Inst. 2000 Jul 19;92(14):1185-6 - PubMed
  15. N Engl J Med. 2016 Oct 13;375(15):1438-1447 - PubMed
  16. J Clin Oncol. 2016 Apr 10;34(11):1190-6 - PubMed
  17. Cell. 2011 Mar 4;144(5):646-74 - PubMed
  18. J Natl Cancer Inst. 2015 Sep 30;107(12 ):djv263 - PubMed
  19. Mol Cancer. 2013 Dec 13;12 :165 - PubMed
  20. Int J Oncol. 2016 Jun;48(6):2497-507 - PubMed
  21. Anticancer Res. 2015 Nov;35(11):6223-9 - PubMed
  22. Oncotarget. 2016 Nov 29;7(48):79032-79046 - PubMed
  23. Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3024-9 - PubMed
  24. J Clin Oncol. 2016 Apr 1;34(10 ):1134-50 - PubMed
  25. Cancer Res. 2011 Jul 1;71(13):4443-53 - PubMed
  26. Am J Pathol. 2012 Nov;181(5):1807-22 - PubMed
  27. Nature. 2013 May 16;497(7449):378-82 - PubMed
  28. Cancer Cell. 2008 May;13(5):394-406 - PubMed
  29. J Natl Cancer Inst. 2013 May 15;105(10):701-10 - PubMed
  30. Nat Rev Clin Oncol. 2015 Jul;12(7):381-94 - PubMed
  31. Cancer Res. 2005 Aug 15;65(16):7065-70 - PubMed

Publication Types

Grant support